Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IL3-C82E3 | Cynomolgus | Biotinylated Cynomolgus IL-33 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
IL3-H52H6 | Human | Human IL-33 (C208S, C227S, C232S, C259S) Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
IL3-M82Q7 | Mouse | Biotinylated Mouse IL-33 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
IL3-H82H5 | Human | Biotinylated Human IL-33 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
IL3-M5245 | Mouse | Mouse IL-33 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL3-C5245 | Cynomolgus | Cynomolgus IL-33 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
IL3-H52H7 | Human | Human IL-33 Protein, His Tag (HPLC verified) | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() ![]() ![]() |
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Torudokimab | LY-3375880 | Eli Lilly And Company | Details | ||
MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Endometriosis | Details |
PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nose Diseases; Dermatitis, Atopic | Details |
Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Regeneron Pharmaceuticals Inc, Sanofi | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Sinusitis; Asthma; Peanut Hypersensitivity; Dermatitis, Atopic; Hypersensitivity | Details |
Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Diabetic Nephropathies; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Dermatitis, Atopic; Respiratory Insufficiency | Details |
This web search service is supported by Google Inc.